mRNA vaccines ‘protective’ in patients with IBD on biologics

A small but reassuring study shows every patient mounted an antibody response, researchers say
Reuters Health Staff writer
Senior woman having vaccination

Patients with inflammatory bowel disease (IBD), even those receiving biologics, are able to mount a significant immune response after getting mRNA COVID-19 vaccines, a study shows.

In an analysis of data from 48 IBD patients, of whom 85% were taking biologics at the time of vaccination with either the Pfizer-BioNTech or Moderna vaccines, all had positive antibody responses.